{"id":507566,"date":"2024-08-05T09:30:26","date_gmt":"2024-08-05T01:30:26","guid":{"rendered":"https:\/\/law.asia\/?p=507566"},"modified":"2024-08-05T14:40:03","modified_gmt":"2024-08-05T06:40:03","slug":"otsuka-pharmaceutical-biotech-acquisition","status":"publish","type":"post","link":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/","title":{"rendered":"Skadden\uacfc Latham &#038; Watkins, 1\uc8705000\uc5b5\ub300 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub9e4\uac01 \uc790\ubb38"},"content":{"rendered":"<p><a href=\"https:\/\/law.asia\/law-firm\/skadden\/\">Skadden, Arps, Slate, Meagher &amp; Flom<\/a>\uacfc <a href=\"https:\/\/law.asia\/law-firm\/latham-watkins-singapore\/\">Latham &amp; Watkins<\/a>\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical\uc758 Jnana Therapeutics \uc778\uc218\ub97c \uc790\ubb38\ud558\uace0 \uc788\ub2e4.<\/p>\n<p>\ucd5c\uc885 \ud569\ubcd1 \uacc4\uc57d\uc5d0 \ub530\ub77c, Otsuka\ub294 \uc778\uc218 \uc644\ub8cc \uc2dc Jnana \uc8fc\uc8fc\ub4e4\uc5d0\uac8c 8\uc5b5 \ub2ec\ub7ec(\uc57d 1\uc870880\uc5b5\uc6d0)\ub97c \uc9c0\uae09\ud560 \uc608\uc815\uc774\uba70, \uc778\uc218\ub294 \uc624\ub294 3\ubd84\uae30\uc5d0 \uc644\ub8cc\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub41c\ub2e4. \ud2b9\uc815 \uac1c\ubc1c \ubc0f \uaddc\uc81c \ub9c8\uc77c\uc2a4\ud1a4 \ub2ec\uc131\uc5d0 \ub530\ub77c \ucd94\uac00\ub85c 3\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 4420\uc5b5\uc6d0)\ub3c4 \uc9c0\uae09\ub420 \uc608\uc815\uc774\ub2e4.<\/p>\n<p><a href=\"https:\/\/law.asia\/law-firm\/skadden\/\">Skadden<\/a>\uc740 \ub3c4\ucfc4\uc5d0 \uac70\uc8fc\ud558\ub294 \ud30c\ud2b8\ub108 Mitsuhiro KAMIYA \ubcc0\ud638\uc0ac\uc640 Palo Alto\uc5d0 \uac70\uc8fc\ud558\ub294 \ud30c\ud2b8\ub108 Mike MIES \ubcc0\ud638\uc0ac\uac00 \uc774\ub044\ub294 \ud300\uc73c\ub85c Otsuka\ub97c \ub300\ub9ac\ud588\ub2e4. \ud30c\ud2b8\ub108 Ken KUMAYAMA, Joe YAFFE, David SCHWARTZ, Nate GIESSELMAN, Michael LEITER, Avia DUNN, Nesa AMAMOO \ubc0f Peter LUNEAU \ubcc0\ud638\uc0ac\uac00 \ucd94\uac00 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4.<\/p>\n<p><a href=\"https:\/\/law.asia\/law-firm\/latham-watkins-singapore\/\">Latham &amp; Watkins<\/a>\ub294 Jnana\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud558\uace0 \uc788\uc73c\uba70, \ud30c\ud2b8\ub108 Leah SAUTER \ubc0f Peter HANDRINOS \ubcc0\ud638\uc0ac\uac00 \ud300\uc744 \uc774\ub04c\uace0 \uc788\ub2e4. \ub610\ud55c \ud30c\ud2b8\ub108 Matthew CONWAY, Katharine MOIR, Aaron GARDNER, Heather DEIXLER, Elizabeth RICHARDS \ubc0f Patrick ENGLISH \ubcc0\ud638\uc0ac\uac00 \uac70\ub798\uc5d0 \ucc38\uc5ec\ud588\ub2e4.<\/p>\n<p>\ubcf4\uc2a4\ud134\uc5d0 \ubcf8\uc0ac\ub97c \ub454 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 Jnana\ub294 \uc77c\ubcf8 \uc81c\uc57d \ud68c\uc0ac\uc778 Otsuka\uc758 \uac04\uc811 \uc790\ud68c\uc0ac\uc778 Otsuka America\ub97c \ud1b5\ud574 Otsuka\uc758 \uc644\uc804 \uc790\ud68c\uc0ac\uac00 \ub420 \uc608\uc815\uc774\ub2e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Skadden, Arps, Slate, Meagher &amp; Flom\uacfc Latham &amp; Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical\uc758 Jnana Therapeutics \uc778\uc218\ub97c \uc790\ubb38\ud558\uace0 \uc788\ub2e4. \ucd5c\uc885 \ud569\ubcd1 \uacc4\uc57d\uc5d0 \ub530\ub77c, Otsuka\ub294 \uc778\uc218 \uc644\ub8cc \uc2dc Jnana \uc8fc\uc8fc\ub4e4\uc5d0\uac8c 8\uc5b5 \ub2ec\ub7ec(\uc57d 1\uc870880\uc5b5\uc6d0)\ub97c \uc9c0\uae09\ud560 \uc608\uc815\uc774\uba70, \uc778\uc218\ub294 \uc624\ub294 3\ubd84\uae30\uc5d0 \uc644\ub8cc\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub41c\ub2e4. \ud2b9\uc815 \uac1c\ubc1c \ubc0f \uaddc\uc81c \ub9c8\uc77c\uc2a4\ud1a4 \ub2ec\uc131\uc5d0 \ub530\ub77c \ucd94\uac00\ub85c 3\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d<\/p>\n","protected":false},"author":18,"featured_media":507516,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":""},"categories":[8398,8532],"tags":[149512,12338,149508,149513,149510,149507,149511,141999,149514,149509],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"Skadden, Arps, Slate, Meagher &amp; Flom\uacfc Latham &amp; Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skadden\uacfc Latham &amp; Watkins, 1\uc8705000\uc5b5\ub300 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub9e4\uac01 \uc790\ubb38\" \/>\n<meta property=\"og:description\" content=\"Skadden, Arps, Slate, Meagher &amp; Flom\uacfc Latham &amp; Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-05T01:30:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-05T06:40:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kient\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\ubd84\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/law.asia\/ko\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/law.asia\/ko\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.instagram.com\/law.asia_\/?hl=en\",\"https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/\",\"https:\/\/www.youtube.com\/@Law.asiaLimited\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/#logo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ko\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law.asia\/ko\/#website\",\"url\":\"https:\/\/law.asia\/ko\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/law.asia\/ko\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law.asia\/ko\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg\",\"width\":900,\"height\":600,\"caption\":\"Skadden\\uacfc Latham & Watkins, 1\\uc8705000\\uc5b5\\ub300 \\uc0dd\\uba85\\uacf5\\ud559 \\uae30\\uc5c5 \\ub9e4\\uac01 \\uc790\\ubb38\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage\",\"url\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/\",\"name\":\"\\uc2a4\\uce74\\ub374\\u00b7\\ub798\\uc378\\uc564\\uc6cc\\ud0a8\\uc2a4, \\uc624\\uce20\\uce74\\uc81c\\uc57d Jnana\\ud14c\\ub77c\\ud4e8\\ud2f1\\uc2a4 11\\uc5b5 2500\\ub9cc \\ub2ec\\ub7ec \\uc778\\uc218 \\uc790\\ubb38\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ko\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage\"},\"datePublished\":\"2024-08-05T01:30:26+00:00\",\"dateModified\":\"2024-08-05T06:40:03+00:00\",\"description\":\"Skadden, Arps, Slate, Meagher & Flom\\uacfc Latham & Watkins\\uac00 \\ucd5c\\ub300 11\\uc5b5 2500\\ub9cc \\ub2ec\\ub7ec(\\uc57d 1\\uc870 5300\\uc5b5\\uc6d0)\\uc5d0 \\ub2ec\\ud558\\ub294 Otsuka Pharmaceutical...\",\"breadcrumb\":{\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#breadcrumb\"},\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage\"},\"author\":{\"@id\":\"https:\/\/law.asia\/ko\/#\/schema\/person\/141af725dc05d2a2e18a5ddb9c4381b7\"},\"headline\":\"Skadden\\uacfc Latham &#038; Watkins, 1\\uc8705000\\uc5b5\\ub300 \\uc0dd\\uba85\\uacf5\\ud559 \\uae30\\uc5c5 \\ub9e4\\uac01 \\uc790\\ubb38\",\"datePublished\":\"2024-08-05T01:30:26+00:00\",\"dateModified\":\"2024-08-05T06:40:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage\"},\"wordCount\":67,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/law.asia\/ko\/#organization\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg\",\"keywords\":[\"Jnana\\ud14c\\ub77c\\ud4e8\\ud2f1\\uc2a4\",\"M&amp;A\",\"\\ub798\\uc378\\uc564\\uc6cc\\ud0a8\\uc2a4\",\"\\ubbf8\\uad6d\\ubc95\\ub960\",\"\\uc0dd\\uba85\\uacf5\\ud559\",\"\\uc2a4\\uce74\\ub374\",\"\\uc624\\uce20\\uce74\\uc81c\\uc57d\",\"\\uc778\\uc218\\ud569\\ubcd1\",\"\\uc77c\\ubcf8\\ubc95\\ub960\",\"\\uc81c\\uc57d\\uc0b0\\uc5c5\"],\"articleSection\":[\"Asia Business Law Journal\",\"\\ub274\\uc2a4\"],\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/law.asia\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/law.asia\/ko\/#\/schema\/person\/141af725dc05d2a2e18a5ddb9c4381b7\",\"name\":\"Kient\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/#personlogo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6defc3c0ff408cd5be618e1fb33ef2f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6defc3c0ff408cd5be618e1fb33ef2f8?s=96&d=mm&r=g\",\"caption\":\"Kient\"},\"url\":\"https:\/\/law.asia\/ko\/author\/van_author5\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"Skadden, Arps, Slate, Meagher & Flom\uacfc Latham & Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/","og_locale":"ko_KR","og_type":"article","og_title":"Skadden\uacfc Latham & Watkins, 1\uc8705000\uc5b5\ub300 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub9e4\uac01 \uc790\ubb38","og_description":"Skadden, Arps, Slate, Meagher & Flom\uacfc Latham & Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical...","og_url":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2024-08-05T01:30:26+00:00","article_modified_time":"2024-08-05T06:40:03+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"Written by":"Kient","Est. reading time":"1\ubd84"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/law.asia\/ko\/#organization","name":"Law.asia","url":"https:\/\/law.asia\/ko\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.instagram.com\/law.asia_\/?hl=en","https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/","https:\/\/www.youtube.com\/@Law.asiaLimited","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/#logo","inLanguage":"ko-KR","url":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law.asia\/ko\/#logo"}},{"@type":"WebSite","@id":"https:\/\/law.asia\/ko\/#website","url":"https:\/\/law.asia\/ko\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law.asia\/ko\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.asia\/ko\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ko-KR"},{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage","inLanguage":"ko-KR","url":"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg","width":900,"height":600,"caption":"Skadden\uacfc Latham & Watkins, 1\uc8705000\uc5b5\ub300 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub9e4\uac01 \uc790\ubb38"},{"@type":"WebPage","@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage","url":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/","name":"\uc2a4\uce74\ub374\u00b7\ub798\uc378\uc564\uc6cc\ud0a8\uc2a4, \uc624\uce20\uce74\uc81c\uc57d Jnana\ud14c\ub77c\ud4e8\ud2f1\uc2a4 11\uc5b5 2500\ub9cc \ub2ec\ub7ec \uc778\uc218 \uc790\ubb38","isPartOf":{"@id":"https:\/\/law.asia\/ko\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage"},"datePublished":"2024-08-05T01:30:26+00:00","dateModified":"2024-08-05T06:40:03+00:00","description":"Skadden, Arps, Slate, Meagher & Flom\uacfc Latham & Watkins\uac00 \ucd5c\ub300 11\uc5b5 2500\ub9cc \ub2ec\ub7ec(\uc57d 1\uc870 5300\uc5b5\uc6d0)\uc5d0 \ub2ec\ud558\ub294 Otsuka Pharmaceutical...","breadcrumb":{"@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#breadcrumb"},"inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"NewsArticle","@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#article","isPartOf":{"@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage"},"author":{"@id":"https:\/\/law.asia\/ko\/#\/schema\/person\/141af725dc05d2a2e18a5ddb9c4381b7"},"headline":"Skadden\uacfc Latham &#038; Watkins, 1\uc8705000\uc5b5\ub300 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub9e4\uac01 \uc790\ubb38","datePublished":"2024-08-05T01:30:26+00:00","dateModified":"2024-08-05T06:40:03+00:00","mainEntityOfPage":{"@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#webpage"},"wordCount":67,"commentCount":0,"publisher":{"@id":"https:\/\/law.asia\/ko\/#organization"},"image":{"@id":"https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/law.asia\/wp-content\/uploads\/2024\/08\/Skadden-Latham-Watkins-steer-USD1.12bn-biotech-sale.jpg","keywords":["Jnana\ud14c\ub77c\ud4e8\ud2f1\uc2a4","M&amp;A","\ub798\uc378\uc564\uc6cc\ud0a8\uc2a4","\ubbf8\uad6d\ubc95\ub960","\uc0dd\uba85\uacf5\ud559","\uc2a4\uce74\ub374","\uc624\uce20\uce74\uc81c\uc57d","\uc778\uc218\ud569\ubcd1","\uc77c\ubcf8\ubc95\ub960","\uc81c\uc57d\uc0b0\uc5c5"],"articleSection":["Asia Business Law Journal","\ub274\uc2a4"],"inLanguage":"ko-KR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law.asia\/ko\/otsuka-pharmaceutical-biotech-acquisition\/#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/law.asia\/#organization"}},{"@type":"Person","@id":"https:\/\/law.asia\/ko\/#\/schema\/person\/141af725dc05d2a2e18a5ddb9c4381b7","name":"Kient","image":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/#personlogo","inLanguage":"ko-KR","url":"https:\/\/secure.gravatar.com\/avatar\/6defc3c0ff408cd5be618e1fb33ef2f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6defc3c0ff408cd5be618e1fb33ef2f8?s=96&d=mm&r=g","caption":"Kient"},"url":"https:\/\/law.asia\/ko\/author\/van_author5\/"}]}},"_links":{"self":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/507566"}],"collection":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/comments?post=507566"}],"version-history":[{"count":3,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/507566\/revisions"}],"predecessor-version":[{"id":507577,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/507566\/revisions\/507577"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/media\/507516"}],"wp:attachment":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/media?parent=507566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/categories?post=507566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/tags?post=507566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}